Your browser doesn't support javascript.
loading
Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
Kwok, Kin On; McNeil, Edward B; Tsoi, Margaret Ting Fong; Wei, Vivian Wan In; Wong, Samuel Yeung Shan; Tang, Julian Wei Tze.
Afiliación
  • Kwok KO; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Shenzhen Research Institute of th
  • McNeil EB; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Tsoi MTF; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Wei VWI; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Wong SYS; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Tang JWT; Respiratory Sciences, University of Leicester, Leicester, United Kingdom; Clinical Microbiology, Leicester Royal Infirmary, Leicester, UK. Electronic address: jwtang49@hotmail.com.
J Infect ; 83(3): 381-412, 2021 09.
Article en En | MEDLINE | ID: mdl-34118274
ABSTRACT
As the COVID-19 pandemic continues, the availability of several different new vaccines, their varying supply levels, effectiveness, and immunity duration across different ethnic populations, together with natural infection rates, will have an impact on when each country can reach herd immunity (ranging from 15.3% to 77.1%). Here we estimate the population proportions still required to gain immunity (ranging from 0.01% to 48.8%) to reach an overall herd immunity level to stop the exponential virus spread in 32 selected countries.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunidad Colectiva / Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: J Infect Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunidad Colectiva / Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: J Infect Año: 2021 Tipo del documento: Article